Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

while semaglutide has been on the market since 2017. There was no word from Novo Nordisk on plans to file the high-dose version for approval, which clearly cuts the efficacy deficit with its main ...

My parents are both retired medical professionals who are in their early 70s. My father has diabetes that he manages with ...

Regular-moderate intensity exercise, while avoiding very intense exercise is probably best for people in their 70s.

My parents are both retired medical professionals who are in their early 70s. My father has diabetes that he manages with medication, and he also has a history of recurrent prostate cancer. My mother ...

A/S, a global healthcare company specializing in diabetes care and other chronic conditions, has been at the forefront of the rapidly expanding GLP-1 market. With a market capitalization of $376.79 ...

Pathologist Dr Margot Bolster said Breeda O’Donoghue's death should be referred to the Health Products Regulatory Authority ...

Dr. George Carroll runs BeSlimMD, a private weight loss clinic in Maitland. He has been helping patients lose weight for more ...

Nearly half of Americans find weight loss challenging. If you’re struggling with weight loss, then you've likely experimented with new diet ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.